Literature DB >> 15258035

Whole body PET/CT imaging for detection of metastatic choroidal melanoma.

P T Finger, M Kurli, P Wesley, L Tena, K R Kerr, A Pavlick.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15258035      PMCID: PMC1772278          DOI: 10.1136/bjo.2003.039289

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.

Authors:  G S Mijnhout; O S Hoekstra; M W van Tulder; G J Teule; W L Devillé
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

Review 2.  Enucleation.

Authors:  D M Moshfeghi; A A Moshfeghi; P T Finger
Journal:  Surv Ophthalmol       Date:  2000 Jan-Feb       Impact factor: 6.048

Review 3.  Combining anatomy and function: the path to true image fusion.

Authors:  D W Townsend; S R Cherry
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 4.  Treatment of metastatic uveal melanoma: review and recommendations.

Authors:  D M Albert; A S Niffenegger; J K Willson
Journal:  Surv Ophthalmol       Date:  1992 May-Jun       Impact factor: 6.048

Review 5.  Radiation therapy for choroidal melanoma.

Authors:  P T Finger
Journal:  Surv Ophthalmol       Date:  1997 Nov-Dec       Impact factor: 6.048

6.  Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients.

Authors:  Susan M Swetter; Lisa A Carroll; Denise L Johnson; George M Segall
Journal:  Ann Surg Oncol       Date:  2002-08       Impact factor: 5.344

7.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

Authors:  M Diener-West; B S Hawkins; J A Markowitz; A P Schachat
Journal:  Arch Ophthalmol       Date:  1992-02

8.  18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.

Authors:  M Stas; S Stroobants; P Dupont; M Gysen; L Van Hoe; M Garmyn; L Mortelmans; I De Wever
Journal:  Melanoma Res       Date:  2002-10       Impact factor: 3.599

9.  Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge.

Authors:  G M Mavligit; C Charnsangavej; C H Carrasco; Y Z Patt; R S Benjamin; S Wallace
Journal:  JAMA       Date:  1988-08-19       Impact factor: 56.272

  9 in total
  5 in total

1.  Whole body PET/CT for initial staging of choroidal melanoma.

Authors:  P T Finger; M Kurli; S Reddy; L B Tena; A C Pavlick
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

2.  Clinicopathological correlation for the role of fluorodeoxyglucose positron emission tomography computed tomography in detection of choroidal malignant melanoma.

Authors:  Toshihiko Matsuo; Yuka Ogino; Kouichi Ichimura; Takehiro Tanaka; Mitsumasa Kaji
Journal:  Int J Clin Oncol       Date:  2013-03-01       Impact factor: 3.402

3.  Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine--a metastatic disease 17 years after complete surgical resection.

Authors:  Darko Katalinic; Branimir Anic; Ranka Stern-Padovan; Miroslav Mayer; Mirna Sentic; Nada Cikes; Kamelija Zarkovic; Snjezana Dotlic; Stjepko Plestina
Journal:  World J Surg Oncol       Date:  2011-11-17       Impact factor: 2.754

4.  Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.

Authors:  Victoria M L Cohen; Efthymia Pavlidou; Joanna DaCosta; Amit K Arora; Teressa Szyszko; Mandeep S Sagoo; Peter Szlosarek
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Apr-Jun

Review 5.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.